A
Anne Craveiro Brøchner
Researcher at University of Southern Denmark
Publications - 43
Citations - 872
Anne Craveiro Brøchner is an academic researcher from University of Southern Denmark. The author has contributed to research in topics: Medicine & Intensive care unit. The author has an hindex of 9, co-authored 29 publications receiving 340 citations. Previous affiliations of Anne Craveiro Brøchner include Odense University Hospital.
Papers
More filters
Journal ArticleDOI
Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure
Olav L. Schjørring,Thomas Lass Klitgaard,Anders Perner,Jørn Wetterslev,Theis Lange,Martin Siegemund,Minna Bäcklund,Frederik Keus,Jon Henrik Laake,Matt Morgan,Katrin Thormar,Søren A. Rosborg,Jannie Bisgaard,Annette E.S. Erntgaard,Anne Sofie H. Lynnerup,Rasmus L. Pedersen,Elena Crescioli,Theis C. Gielstrup,Meike T. Behzadi,Lone Musaeus Poulsen,Stine Estrup,Jens Laigaard,Cheme Andersen,Camilla Bekker Mortensen,Björn A. Brand,Jonathan White,Inge Lise Jarnvig,Morten Hylander Møller,Lars Quist,Morten H. Bestle,Martin Schønemann-Lund,Maj K. Kamper,Mathias Hindborg,Alexa Hollinger,Caroline E. Gebhard,Núria Zellweger,Christian S. Meyhoff,Mathias Hjort,Laura K. Bech,Thorbjørn Grøfte,Helle Bundgaard,Lars Ostergaard,Maria A. Thyø,Thomas Hildebrandt,Bülent Uslu,Christoffer Sølling,Nette Møller-Nielsen,Anne Craveiro Brøchner,Morten Borup,Marjatta Okkonen,Willem Dieperink,Ulf Gøttrup Pedersen,Anne Sofie Andreasen,Lone Buus,Tayyba N. Aslam,Robert Winding,Joerg C. Schefold,Stine B. Thorup,Susanne Iversen,Janus Engstrøm,Maj Brit Nørregaard Kjær,Bodil Steen Rasmussen +61 more
TL;DR: In this paper, the benefits and harms of different oxygenation levels for patients with acute hypoxemic respiratory failure in the intensive care unit (ICU) were discussed. But, the benefits of different levels of oxygenation were not evaluated.
Journal ArticleDOI
Pathophysiology of the systemic inflammatory response after major accidental trauma.
TL;DR: Postponement of final reconstructive surgery until the inflammatory response is normalized should be based on prospective randomized trials, however, this statement is however not based on clinical trials.
Journal ArticleDOI
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
Marie Warrer Munch,Sheila Nainan Myatra,Bharath Kumar Tirupakuzhi Vijayaraghavan,Sanjith Saseedharan,Thomas Benfield,Rebecka Rubenson Wahlin,Bodil Steen Rasmussen,Anne Sofie Andreasen,Lone Musaeus Poulsen,Luca Cioccari,Mohd Saif Khan,Farhad N Kapadia,Jigeeshu V Divatia,Anne Craveiro Brøchner,Morten H. Bestle,Marie Helleberg,Jens Michelsen,Ajay Padmanaban,Neeta Bose,Anders Pape Møller,Kapil Borawake,Klaus Tjelle Kristiansen,Urvi Shukla,Michelle S Chew,Subhal Dixit,Charlotte Suppli Ulrik,Pravin Amin,Rajesh Chawla,Christian A Wamberg,Mehul S Shah,Iben S Darfelt,Vibeke Lind Jørgensen,Margit Smitt,Anders Granholm,Maj-Brit Nørregaard Kjaer,Morten Hylander Møller,Tine Sylvest Meyhoff,Gitte Kingo Vesterlund,Naomi E Hammond,Naomi E Hammond,Sharon Micallef,Abhinav Bassi,Oommen John,Oommen John,Anubhuti Jha,Maria Cronhjort,Stephan M. Jakob,Christian Gluud,Christian Gluud,Theis Lange,Vaijayanti Kadam,Klaus Marcussen,Jacob Hollenberg +52 more
TL;DR: In this article, the effects of 12 mg vs 6 mg/d of dexamethasone in patients with COVID-19 and severe hypoxemia were evaluated in a randomized clinical trial at 26 hospitals in Europe and India.
Journal ArticleDOI
Characteristics, interventions and longer-term outcomes of COVID-19 ICU patients in Denmark - a nationwide, observational study.
Nicolai Haase,Ronni Plovsing,Steffen Christensen,Lone Musaeus Poulsen,Anne Craveiro Brøchner,Bodil Steen Rasmussen,Marie Helleberg,Jens-Ulrik Stæhr Jensen,Lars Peter Kloster Andersen,Hanna Siegel,Michael Ibsen,Vibeke Lind Jørgensen,Robert Winding,Susanne Iversen,Henrik Pedersen,Jacob Madsen,Christoffer Sølling,Ricardo Sanchez Garcia,Jens Michelsen,Thomas Mohr,Anne Mannering,Ulrick Skipper Espelund,Helle Bundgaard,Lynge Kirkegaard,Margit Smitt,David Levarett Buck,Niels Erik Ribergaard,Helle B.S. Pedersen,Birgitte V. Christensen,Anders Perner +29 more
TL;DR: Characteristics, interventions and longer term outcomes of the entire, unselected cohort of all ICU patients with COVID‐19 in Denmark where the ICU capacity was not exceeded are presented.
Journal ArticleDOI
Restriction of Intravenous Fluid in ICU Patients with Septic Shock.
Tine Sylvest Meyhoff,Peter Buhl Hjortrup,Jørn Wetterslev,Praleene Sivapalan,Jon Henrik Laake,Maria Cronhjort,Stephan M. Jakob,Maurizio Cecconi,Marek Nalos,Marlies Ostermann,Manu L N G Malbrain,Ville Pettilä,Morten Hylander Møller,Maj Brit Nørregaard Kjær,Theis Lange,Christian Overgaard-Steensen,Björn A. Brand,Marie Winther-Olesen,Jonathan White,Lars Quist,B. Westergaard,Andreas Bender Jonsson,Carl Johan Steensen Hjortsø,Nick Meier,Thomas Steen Jensen,Janus Engstrøm,Lars Nebrich,Nina Christine Andersen-Ranberg,Jacob V. Jensen,Neeliya A Joseph,Lone Musaeus Poulsen,Louise S Herløv,Christoffer Sølling,Susan K Pedersen,Kurt Krogh Knudsen,Therese Simonsen Straarup,Marianne L. Vang,Helle Bundgaard,Bodil Steen Rasmussen,S. Aagaard,Thomas B. Hildebrandt,Lene Russell,Morten H. Bestle,Martin Schonemann-Lund,Anne Craveiro Brøchner,Claes Elvander,S Hoffmann,Michael L. Rasmussen,Yvonne K Martin,F Friberg,Herman Seter,Tayyba N. Aslam,Sigrid Ådnøy,Philipp Seidel,Kristian Strand,B. Johnstad,Eva Joelsson-Alm,Jens Christensen,Christian Ahlstedt,Carmen A. Pfortmueller,Martin Siegemund,Massimiliano Greco,Jaroslav Radej,Miroslav Kriz,Doug W Gould,Kathryn M Rowan,Paul R Mouncey,Anders Perner +67 more
TL;DR: Among adult patients with septic shock in the ICU, intravenous fluid restriction did not result in fewer deaths at 90 days than standard intravenousfluid therapy, and days alive and out of the hospital were similar in the two groups.